Unresolved questions about the most successful known parasite

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 2, 2011, Pages 169-171

  Ajzenberg, Daniel ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

CONFERENCE PAPER; CONGENITAL TOXOPLASMOSIS; DRUG EFFICACY; DRUG TOLERANCE; HOST PARASITE INTERACTION; HUMAN; INTRAUTERINE INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PARASITEMIA; PRENATAL DRUG EXPOSURE; PRENATAL SCREENING; SEROCONVERSION; SOUTH AMERICA; THERAPY EFFECT; TOXOPLASMA GONDII; TOXOPLASMOSIS; TROPICAL DISEASE; VERTICAL TRANSMISSION;

ANIMALS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTERNATIONAL COOPERATION; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL CARE; PYRIMETHAMINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOUTH AMERICA; SPIRAMYCIN; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL; TOXOPLASMOSIS, OCULAR;

EID: 79952176859     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.169     Document Type: Conference Paper

References (9)

1. Gilbert RE, Freeman K, Lago EG et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2(8), e277 (2008).
2. de-la-Torre A, González G, Díaz-Ramirez J, Gómez-Marín JE. Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am. J. Ophthalmol. 143(2), 354-356 (2007).
3. Glasner PD, Silveira C, Kruszon-Moran D et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am. J. Ophthalmol. 114(2), 136-144 (1992).
4. Ajzenberg D, Bañuls AL, Su C et al. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int. J. Parasitol. 34(10), 1185-1196 (2004).
5. Desmonts G, Couvreur J. Congenitaltoxoplasmosis. A prospective study of 378 pregnancies. N. Engl. J. Med. 290(20), 1110-1116 (1974).
6. Thiébaut R, Leproust S, Chêne G, Gilbert R. SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369(9556), 115-122 (2007).
7. Cortina-Borja M, Tan HK, Wallon M et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 7(10), pii: e1000351 (2010).
8. Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int. J. Epidemiol. 30(6), 1303-1308 (2001).
9. Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy (TOXOGEST) http://clinicaltrials.gov/ct2/ show/NCT01189448?term=NCT01189448&rank=1